Are We Closer to Personalized Medicine in MS?
Feb 15, 2016
Are We Closer to Personalized Medicine in MS?
Disclaimers
Program Goals
What Is Personalized Medicine?
What Is Personalized Medicine? (cont)
Prognostic Indicators
Biomarkers: JC Virus Antibody Index
Biomarkers
Patient Factors
Drug Factors
Assessing Risk
Experience With MS Drugs: Clinical Practice vs Clinical Trials
Monitoring Response
Monitoring Response: Modified Rio Score
Monitoring Response (cont)
Switching and Sequencing Therapy
Risk Stratification at Diagnosis -- and Beyond
On the Horizon: Agents in Development
On the Horizon: Reduced Injections
Summary and Key Points
Abbreviations
References
References (cont)
References (cont)
References (cont)
References (cont)